Phase II Study of the Angiopoietin-1 and -2 Peptibody AMG 386 for the Treatment of Angiosarcoma
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2015
At a glance
- Drugs Trebananib (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 16 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Mar 2015 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov record.